Below are Gilead’s Research Scholar Program Liver Disease Awardees and their research titles. As the program values diverse voices and innovative research topics to address areas of unmet medical need, you do not need to duplicate previous research topics in order to be successful for an Award.
Any research proposal that addresses an area of unmet medical need in Liver Disease is welcome.
For other examples of exceptional applications, please visit the NIH’s RO1 sample applications through this helpful resource: https://www.niaid.nih.gov/grants-contracts/sample-applications
2023 Recipients
Jonggi Choi, MD, PhD
Asan Medical Center
Seoul, South Korea
“Development of Machine Learning-based Models using Big Data for Diagnosis and Prediction of Outcomes in Liver Disease”
Zhou Jin, PhD
Duke-NUS Medical School
Singapore
“Targeting dysregulated protein synthesis in nonalcoholic steatohepatitis”
2022 Recipient
Rio Sugimura, MD, PhD
University of Hong Kong
Hong Kong SAR China
“Targeting uPAR in tumor-associated macrophages of hepatocellular carcinoma”
2021 Recipients
Valerie Chew, PhD
Translational Immunology Institute (TII), SingHealth-DukeNUS
Singapore
“Discovery of biomarkers and novel therapeutic strategies for immunotherapy in Hepatocellular carcinoma”
Yotaro Kudo, MD, PhD
The University of Tokyo
Tokyo, Japan
“The Novel Role of Atypical Protein Kinases C as Key Regulators for Biliary Development, Regeneration, and Tumorigenesis”
Sadahisa Ogasawara, MD, PhD
Chiba University
Chiba, Japan
“Understandings the mechanism of energy metabolization in intratumor immune microenvironment in metabolic related hepatocellular carcinoma”
2020 Recipients
Hyuk Soo Eun, MD, PhD
Chungham National University Hospital
Daejeon, South Korea
"The major role of NADPH Oxidase 2 – mTORC1 axis in nonalcoholic fatty liver disease-associated hepatocellular carcinoma "
Nai Yang Fu, PhD
Duke-NUS Medical School
Singapore
"Exploring the potential of TSPAN8 as a novel biomarker and therapeutic target of hepatocellular carcinoma"
Yuichi Hara, MD
Kawasaki Medical School
Okayama, Japan
"Elucidation of the mechanism underlying iron loss-induced mitophagy and its role in suppression of hepatocellular carcinoma in nonalcoholic steatohepatitis"
Jung Chen Su, PhD
National Yang Ming University
Taipei, Taiwan
"Identification of Transcription Factor Targets Regulating Multi-Kinases and Acquired Resistance Genes for Drug Development in Hepatocellular Carcinoma”
2019 Recipients
Yun Shen Chan, PhD
Genome Institute of Singapore
Singapore
"Unraveling The Molecular Response of NASH Treatment Drugs Using an in Vitro Human Adult Stem Cell Derived Liver Organoid Model"
Thuy Thi Thanh Le, MD, PhD
Osaka City University
Osaka, Japan
"Exploration The Novel Role of Cytoglobin As Therapeutic Approach For Liver Fibrosis And Cancer"
Hyon-Seung Yi, MD, PhD
Chungnam National University
Daejeon, South Korea
"The Role of Activating Transcription Factor 5-Mediated Mitochondrial Unfolded Protein Response in Fatty Liver Disease"
Yuchen Xia, PhD
Wuhan University
Hubei, China
"Dissecting Hepatitis B Virus Covalently Closed Circular DNA"
2018 Award Recipients
Li-Rung Huang, PhD
National Health Research Institutes
Miaoli County, Taiwan
"Development of T-cell Immunotherapy Able to Resist T-cell Exhaustion for Treatment of Hepatocellular Carcinoma"
Ruqi Tang, PhD
Shanghai Jiao Tong University
Shanghai, China
"Interplay of Host Genetics and Gut Microbiota in Primary Biliary Cholangitis"
2017 Award Recipients
Hye Won Lee, MD, PhD
Yonsei University College of Medicine
Seoul, South Korea
"Cell-Free Circulating Tumor DNA as a New Possible Predictive Biomarker in Hepatocellular Carcinoma Development in Asian Patients with Chronic Liver Disease"
Sheng-Han Wang, PhD
National Taiwan University College of Medicine
Taipei, Taiwan
"Hepatocel/ular Carcinoma in HBV/HCV Dual Infection Patients: How Many are Contributed or Primed by HBV Infection as Revealed by Tumor Integrated HBV DNA Analysis?"
2016 Award Recipients
Young-Sun Lee, MD, PhD
Korea University College of Medicine
Seoul, Korea
"Investigating the Roles of CX3CR1 Related with Functional Polarization of Tissue-Resident Macrophages in Alcoholic Liver Disease"
Chuanlong Zhu, MD, PhD
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China
"Develop Novel Anti-HBV Strategies Based on the Role of EFTUD2 in Innate Immunity"
November 2023, IHQ-UNB-4995